Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2026-03-09 @ 2:45 AM
Study NCT ID:
NCT03788434
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2018-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Sponsor:
Vedanta Biosciences, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clostridium Difficile Infection Recurrence | View |
| None | Clostridium Difficile Infection | View |
| None | Clostridium Difficile | View |
| None | Clostridioides Difficile Infection Recurrence | View |
| None | Clostridioides Difficile Infection | View |
| None | Clostridioides Difficile | View |
| None | CDI | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Clostridium Difficile Infection Recurrence | View |
| None | Clostridium Difficile Infection | View |
| None | Clostridium Difficile | View |
| None | VE303 | View |
| None | Consortium | View |
| None | Vedanta | View |
| None | CDI | View |
| None | C. Diff | View |
| None | CDiff | View |
| None | Clostridiodes Difficile Infection Recurrence | View |
| None | Clostridiodes Difficile Infection | View |
| None | Clostridioides Difficile | View |